Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J1440 · per 1 ML

Fecal microbiota jslm 1 ml

Products billed under this code include Rebyota.

Payment limit per 1 ML, by effective quarter, 4Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1440

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Rebyota Ferring Pharmaceuticals Inc. 55566-9800-02 150 $9,873.90

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $65.826 +$0.222 1 ML Fecal microbiota jslm 1 ml v1, posted September 17, 2026
3Q26 $65.604 +$1.282 1 ML Fecal microbiota jslm 1 ml v1, posted September 15, 2026
2Q26 $64.322 −$0.303 1 ML Fecal microbiota jslm 1 ml v1, posted September 15, 2026
1Q26 $64.625 +$0.786 1 ML Fecal microbiota jslm 1 ml v1, posted September 15, 2026
4Q25 $63.839 −$0.191 1 ML Fecal microbiota jslm 1 ml v1, posted September 8, 2026
3Q25 $64.03 +$0.096 1 ML Fecal microbiota jslm 1 ml v1, posted March 10, 2026
2Q25 $63.934 +$0.334 1 ML Fecal microbiota jslm 1 ml v1, posted March 10, 2026
1Q25 $63.60 +$0.30 1 ML Fecal microbiota jslm 1 ml v1, posted December 19, 2025
4Q24 $63.30 +$0.018 1 ML Fecal microbiota jslm 1 ml v1, posted June 11, 2025
3Q24 $63.282 +$0.076 1 ML Fecal microbiota jslm 1 ml v1, posted June 11, 2025
2Q24 $63.206 +$0.222 1 ML Fecal microbiota jslm 1 ml v1, posted March 11, 2025
1Q24 $62.984 +$0.561 1 ML Fecal microbiota jslm 1 ml v1, posted December 19, 2024
4Q23 $62.423 – 1 ML Fecal microbiota jslm 1 ml v1, posted October 10, 2024

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files